10-Year Data Back Early Start to Biologics in Arthritic Diseases

(MedPage Today) -- Many patients treated with golimumab (Simponi) for newly diagnosed peripheral spondyloarthritis (pSpA) in a small trial achieved sustained drug-free remission after 10 years of follow-up, researchers found. With 49 of the trial...